Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
The word “psychedelic” (psyche (i.e., the mind or soul) and delos (i.e., to show)) has Greek origin and was first coined by psychiatrist Humphry Osmond in 1956, who had been conducting research on lysergic acid diethylamide (LSD) at the time. Psychedelic drugs such as <i>N</i>,<i>N...
Main Authors: | Henry Lowe, Ngeh Toyang, Blair Steele, Justin Grant, Amza Ali, Lorenzo Gordon, Wilfred Ngwa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/8/2520 |
Similar Items
-
The Therapeutic Potential of Psilocybin
by: Henry Lowe, et al.
Published: (2021-05-01) -
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
by: Marvin M. Urban, et al.
Published: (2023-04-01) -
Psychedelics and psychiatric disorders: A emerging role
by: C. Peixoto, et al.
Published: (2021-04-01) -
The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences
by: Tomas Frymann, et al.
Published: (2022-05-01) -
Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges
by: Brian S. Barnett, et al.
Published: (2023-10-01)